Related Experiment Videos
Comparison of early performance indicators for screening projects within the European Breast Cancer Network:
M J M Broeders1, A Scharpantgen, N Ascunce
1Department of Epidemiology and Biostatistics (252), Radbond University, Nijmegen Medical Centre, Geert Grooteplein 21, 6525 EZ Nijmegen, The Netherlands. M.Broeders@epib.umcn.nl
Summary
Centralized breast cancer screening projects achieved higher participation rates than decentralized ones. However, cancer detection rates were similar, suggesting differing population-level impacts on mortality.
Area of Science:
- Public Health
- Oncology
- Health Services Research
Background:
- The European Breast Cancer Network (EBCN) was established in 1989 to support pilot breast cancer screening projects.
- Early performance indicators were collected from these projects to assess their effectiveness.
- Understanding the impact of organizational settings on screening performance is crucial.
Purpose of the Study:
- To report early performance indicators for EBCN breast cancer screening projects.
- To compare performance between centralized and decentralized healthcare environments.
- To evaluate the influence of organizational setting on screening participation and outcomes.
Main Methods:
- Data from 10 EBCN projects across six European countries (1989-2000) were analyzed.
- Performance indicators included invitations, examinations, and detected breast cancers.
- Results were stratified by centralized versus decentralized healthcare settings.
- European Guidelines for quality assurance in mammography screening served as reference values.
Main Results:
- Centralized projects demonstrated significantly higher participation rates (74% in 1998) compared to decentralized projects (33%).
- Invitation systems and screening policies were comparable between the two settings.
- No significant differences were observed in cancer detection rates or cancer characteristics.
- Decentralized projects reached a smaller proportion of the target population.
Conclusions:
- While centralized breast cancer screening projects show higher participation, detection rates are similar across organizational settings.
- The differing reach of decentralized projects may impact population-level mortality reduction.
- Optimizing screening delivery models is essential for maximizing public health benefits.